Physician profile
Travis Koeneke
NPI 1942305677
$21,734.65
in general payments reported to CMS, 2019-2025
85 companies · $3,756 in 2025
The $3,756 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,265 · 2020: $3,049 · 2021: $3,633 · 2022: $3,351 · 2023: $2,733 · 2024: $2,947 · 2025: $3,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,630 · Consulting Fee: $780 · Education: $25.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,630.12 |
| Consulting Fee | $780.00 |
| Education | $25.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,311.27 | 2019-2025 | |
| Pfizer INC. | $1,286.12 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,223.86 | 2019-2025 | Enhertu, Lynparza, Calquence |
| Rigel Pharmaceuticals, INC. | $1,046.58 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Abbvie INC. | $993.21 | 2019-2025 | |
| Verastem, INC. | $893.10 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $862.51 | 2020-2023 | Xpovio |
| Genentech USA, INC. | $850.37 | 2019-2025 | Tecentriq, Polivy, Phesgo |
| Eagle Pharmaceuticals, INC. | $850.00 | 2022 | |
| Janssen Biotech, INC. | $805.58 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| Geron Corporation | $800.38 | 2025 | Rytelo |
| E.R. Squibb & Sons, L.L.C. | $725.40 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $574.35 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $520.89 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Verity Pharmaceuticals INC. | $500.00 | 2021 |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $492.78 | 2019-2023 | Kyprolis, Lumakras |
| Glaxosmithkline, LLC. | $431.42 | 2019-2025 | Ojjaara, Zejula, Jemperli |
| Incyte Corporation | $428.65 | 2020-2025 | Jakafi, Monjuvi |
| Daiichi Sankyo INC. | $426.99 | 2020-2025 | Enhertu |
| Genzyme Corporation | $414.91 | 2019-2025 | |
| Lilly USA, LLC | $409.18 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Emd Serono, INC. | $405.37 | 2019-2025 | Bavencio |
| Takeda Pharmaceuticals U.S.A., INC. | $381.16 | 2019-2025 | Ninlaro, Iclusig, Alunbrig |
| Astellas Pharma US INC | $367.46 | 2019-2025 | Xtandi, Padcev, Xospata |
| Seagen INC. | $343.13 | 2019-2023 | Padcev, Adcetris |
| Array Biopharma INC | $340.77 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Gilead Sciences, INC. | $310.69 | 2021-2025 | Trodelvy |
| Kite Pharma, INC. | $204.75 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $191.08 | 2019-2023 | |
| Eisai INC. | $177.73 | 2019-2024 | |
| Exelixis INC. | $172.64 | 2021-2025 | Cabometyx |
| Regeneron Healthcare Solutions, INC. | $166.00 | 2021-2025 | Libtayo |
| Aveo Pharmaceuticals, INC. | $151.10 | 2021-2025 | Fotivda |
| Ipsen Biopharmaceuticals, INC | $141.63 | 2020-2025 | Onivyde, Tazverik |
| Tersera Therapeutics LLC | $137.57 | 2021-2025 | Zoladex, Xermelo |
| Servier Pharmaceuticals LLC | $133.22 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $118.28 | 2019-2025 | Zepzelca |
| Pharmacyclics LLC, An Abbvie Company | $107.60 | 2020-2023 | Epkinly, Imbruvica |
| Sobi, INC | $107.03 | 2022-2025 | |
| Beigene USA, INC. | $100.49 | 2020-2022 | |
| Apellis Pharmaceuticals, INC. | $96.04 | 2023-2024 | Empaveli |
| Alexion Pharmaceuticals, INC. | $92.63 | 2021-2024 | Ultomiris |
| Blue Earth Diagnostics | $90.09 | 2021-2024 | |
| Spectrum Pharmaceuticals INC. | $87.73 | 2024-2025 | Rolvedon |
| Acrotech Biopharma INC. | $87.55 | 2021-2024 | Beleodaq |
| Dendreon Pharmaceuticals LLC | $74.97 | 2019-2025 | Provenge |
| Stemline Therapeutics INC. | $72.82 | 2023-2025 | Orserdu |
| Springworks Therapeutics, INC. | $72.77 | 2024-2025 | Ogsiveo |
| Taiho Oncology, INC. | $70.31 | 2019-2025 | |
| Pharmaessentia USA Corporation | $65.93 | 2024-2025 | Besremi |
| Myriad Genetic Laboratories, INC. | $63.62 | 2022-2024 | Myrisk |
| Pharmacosmos Therapeutics INC. | $57.54 | 2024-2025 | Monoferric, Cosela |
| G1 Therapeutics, INC. | $54.79 | 2022-2023 | Cosela |
| Mylan Institutional INC. | $54.57 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $51.97 | 2022-2024 | Yonsa, Odomzo |
| Agios Pharmaceuticals, INC. | $48.60 | 2022-2024 | |
| Puma Biotechnology, INC. | $44.68 | 2020-2021 | |
| Deciphera Pharmaceuticals INC. | $43.03 | 2021 | |
| Legend Biotech USA INC. | $42.47 | 2025 | Carvykti |
| Epizyme, INC. | $42.18 | 2020-2021 | |
| Kyowa Kirin, INC. | $32.67 | 2021-2022 | |
| Mirati Therapeutics, INC. | $32.23 | 2023 | Krazati |
| Myovant Sciences INC. | $30.24 | 2021-2022 | |
| Aurobindo Pharma USA, INC. | $30.00 | 2020 | |
| Tempus Ai, INC | $29.39 | 2024 | Xt Cdx |
| Iovance Biotherapeutics, INC. | $28.27 | 2025 | Amtagvi |
| Blueprint Medicines Corporation | $26.19 | 2020-2021 | |
| Adma Biomanufacturing LLC | $26.08 | 2021 | |
| Novocure INC. | $21.17 | 2025 | Optune Lua (Novottf-200t) |
| Foundation Medicine, INC. | $20.50 | 2023 | |
| Genmab U.S., INC. | $19.88 | 2024 | Tivdak |
| Adc Therapeutics America, INC. | $19.40 | 2024 | |
| Caris Mpi, INC. | $19.07 | 2025 | Mi Cancer Seek |
| Tg Therapeutics, INC. | $18.27 | 2022 | |
| Allergan, INC. | $17.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.22 | 2025 | |
| Clovis Oncology, INC. | $16.76 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $15.75 | 2020 | |
| Sumitomo Pharma America, INC. | $15.62 | 2023 | Orgovyx |
| Beone Medicines USA, INC. | $14.88 | 2025 | Brukinsa |
| Tesaro, INC. | $14.62 | 2019 | |
| Octapharma USA, INC. | $14.07 | 2023 | Octagam Immune Globulin (Human) |
| Dova Pharmaceuticals | $13.37 | 2019 | |
| Cti Biopharma Corp. | $13.01 | 2023 | Vonjo |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
Rytelo $800Enhertu $435Xtandi $326Keytruda $260Reblozyl $239Lynparza $231Padcev $226Verzenio $213Opdivo $200Erleada $192Braftovi $185Mektovi $185Lorbrena $177Darzalex $173Trodelvy $166Talzenna $162Elrexfio $156Scemblix $154Ibrance $147Adcetris $143Ojjaara $137Jakafi $137Inlyta $137Monjuvi $134Ninlaro $132Imbruvica $132Cabometyx $125Tukysa $123Pomalyst $120Orgovyx $118Sarclisa $117Bavencio $117Comirnaty $114Tecvayli $113Talvey $112Calquence $109Kisqali $109Epkinly $108Tecentriq $108Polivy $108Fotivda $108Libtayo $104Phesgo $101Pluvicto $98.16Carvykti $97.62Empaveli $96.04Zepzelca $95.49Elahere $94.38Xalkori $94.15Rezlidhia $93.94Tavalisse $93.94Rolvedon $87.73Bosulif $87.43Fabhalta $85.99Rybrevant $84.71Perjeta $80.89Paxlovid $78.21Zoladex $74.13Jemperli $73.53Zejula $73.53Orserdu $72.82Ogsiveo $72.77Opdualag $71.21Onivyde $68.80Doptelet $67.81Lenvima $67.07Besremi $65.93Venclexta $65.39Tibsovo $64.28Itovebi $60.10Provenge $58.03Cosela $56.80Mekinist $51.17Welireg $50.38Imfinzi $49.57Xyntha $48.72Benefix $48.72Hympavzi $48.72Columvi $48.16Piqray $47.81Lunsumio $46.16Jaypirca $45.92Iclusig $45.41Gavreto $45.40Xospata $44.78Alunbrig $43.91Posluma $42.50Inqovi $42.19Lonsurf $42.19Vyloy $40.29Yonsa $38.37Odomzo $38.37Fruzaqla $38.23Monoferric $38.10Jevtana $37.77Retevmo $37.08Beleodaq $34.99Myrisk $34.35Krazati $32.23Xermelo $30.91
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Koeneke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.